Griseofulvin solvate solid dispersions with synergistic effect against fungal biofilms by Al-Obaidi, H. et al.
WestminsterResearch
http://www.westminster.ac.uk/westminsterresearch
Griseofulvin solvate solid dispersions with synergistic effect 
against fungal biofilms
Al-Obaidi, H., Kowalczyk, R.M., Kalgudi, R. and Zariwala, M.
NOTICE: this is the authors’ version of a work that was accepted for publication in 
Colloids and Surfaces B: Biointerfaces. Changes resulting from the publishing process, 
such as peer review, editing, corrections, structural formatting, and other quality control 
mechanisms may not be reflected in this document. Changes may have been made to 
this work since it was submitted for publication. A definitive version was subsequently 
published in Colloids and Surfaces B: Biointerfaces, 184, 2019.
The final definitive version in Colloids and Surfaces B: Biointerfaces is available online 
at:
https://dx.doi.org/10.1016/j.colsurfb.2019.110540
© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
https://creativecommons.org/licenses/by-nc-nd/4.0/
The WestminsterResearch online digital archive at the University of Westminster aims to 
make the research output of the University available to a wider audience. Copyright and 
Moral Rights remain with the authors and/or copyright owners.
Griseofulvin solvate solid dispersions with synergistic effect against 1 
fungal biofilms  2 
 3 
Running title: Griseofulvin solvates against fungal biofilms  4 
 5 
Hisham Al-Obaidi *1, Radoslaw M. Kowalczyk2, Rachith Kalgudi3, 6 
Mohammed Gulrez Zariwala3 7 
 8 
1The School of Pharmacy, University of Reading, Reading RG6 6AD, UK  9 
2 Chemical Analysis Facility, University of Reading, Reading RG6 6AD, United 10 
Kingdom 11 
3 Faculty of Science & Technology, University of Westminster, 115 New 12 








*Corresponding author: 21 
h.al-obaidi@reading.ac.uk  22 
 23 
 24 
Keywords: Fungal biofilms, solvates, saturation solubility, thermal analysis  25 
Abstract  26 
Fungal biofilms are invariably recalcitrant to antifungal drugs and thus can 27 
cause recurrent serious infections. The aim of this work was to prepare highly 28 
effective form of the antifungal drug griseofulvin using the chloroform solvate 29 
embedded into different polymeric matrices. Based on their solid solubility, 30 
solvated (chloroform) and non-solvated (methanol and acetone) solid 31 
dispersions were prepared using different materials: silica, microcrystalline 32 
cellulose, polyvinylpyrrolidone and hydroxypropyl methylcellulose acetate 33 
succinate (HPMCAS) by which HPMCAS dispersions showed the highest 34 
solubility of about 200 μg/mL compared with ~30 μg/mL for pure griseofulvin.  35 
The anti fungal potential of griseofulvin was assessed against the 36 
dermatophytes T. rubrum.  Metabolic and protease activity of T. rubrum NCPF 37 
935 with and without the presence of GF:HPMCAS chloroform solvates 38 
showed significant reduction compared to the untreated control after 24 h 39 
period. Confocal laser scanning microscopy showed thin hyphae compared to 40 
Control and GF:HPMCAS (non solvated).  Dynamic vapour sorption data 41 
showed that HPMCAS formed most stable solvate structure preventing 42 
recrystallization and solvate expulsion, which could explain the disruptive 43 
effect of the biofilms. This could be explained by the formed hydrogen bonds 44 
as revealed by the solid and liquid state NMR data, which was further 45 





1. Introduction  51 
  52 
Biofilms are surface-associated microbial communities that exist within a self-53 
secreted matrix consisting primarily of polysaccharides, proteins and nucleic 54 
acids forming the biofilm extracellular matrix (ECM) [1, 2]. Biofilm structures 55 
formed by fungi may present favourable conditions for survival within an 56 
infected host [3]. Dermatophytes such as T. rubrum,  keratinolytic, saprophytic 57 
fungi, are known to form biofilm and commonly implicated as a common 58 
cause for athlete’s foot and fungal infection of the nails [4]. Griseofulvin is one 59 
of the most commonly used antimicrobials to treat dermatophytosis caused by 60 
T. rubrum [5] nevertheless, there have been reports of increased incidence of 61 
resistance to griseofulvin, which makes treatment with griseofulvin less 62 
effective [6, 7]. This could be attributed to the biofilm formation and longer 63 
duration needed to complete the treatment.    64 
 65 
The low aqueous solubility of griseofulvin makes its formulation particularly 66 
challenging for oral drug delivery , which results in larger doses needed to 67 
reach a therapeutic level. Hence, the challenge in improving the antifungal 68 
activity of griseofulvin is two folds; first to improve its aqueous solubility and 69 
secondly to overcome resistance due to biofilm formation.  Crystal 70 
modifications of drug forming metastable drug polymorphs, hydrates, and co-71 
crystals have been among various approaches to improve aqueous solubility 72 
of drugs [8-10].  73 
 74 
Solvates (also known as pseudopolymorphs) comprise of solvent-drug 75 
crystals, which have completely different structural configuration to the parent 76 
drug crystals [11].  Recently, it has been shown that ethanol solvates can 77 
significantly improve the dissolution of pioglitazone with potential 78 
enhancement of in vivo levels in beagle dogs [12].  It is generally agreed that 79 
solvates can form through either adsorption to the crystal cell surface or 80 
though occupying voids within imperfect crystals [13].  It was shown recently 81 
that dextran shell nanoparticles eradicated biofilms of various multidrug-82 
resistant Gram-positive bacteria [14].  This effect was attributed to improved 83 
solubility of the bacteria-nanoparticles complex due to the presence of the 84 
dextran shell [14].  Based on chloroform solvate, the aim of this work was to 85 
prepare a highly synergistic solvate form of griseofulvin able to diffuse across 86 
the biofilms and enhance their solubility.  The solvate form is stabilised within 87 
a polymeric matrix, which will also help to enhance the aqueous solubility of 88 
the embedded drug.   89 
 90 
Griseofulvin (GF) was embedded within different matrices, namely silica, 91 
microcrystalline cellulose (MCC), polyvinylpyrrolidone  (PVP) and 92 
hydroxypropyl methylcellulose acetate succinate (HPMCAS). GF and the 93 
polymer dispersions were prepared using acetone, methanol and chloroform 94 
as solvents. They were selected because of their distinct properties in terms 95 
of hydrogen bonds formation, boiling point and polarity.  Chloroform and 96 
methanol are Lewis acids with unique properties of chloroform to form Cl…Cl 97 
interactions while acetone is Lewis base with distinct proton accepting 98 
capability. By using different matrices, it was possible to evaluate the impact 99 
of drug excipient interactions on crystallization behaviour.  Silica is amorphous 100 
that lacks hydrogen bonding ability, PVP is a Lewis base amorphous polymer 101 
able to accept hydrogen bonds, MCC is partially crystalline able to accept and 102 
donate hydrogen bonds while HPMCAS is amorphous polymer and hydrogen 103 
bond acceptor and donor.  104 
 105 
 106 
2. Experimental Section 107 
2.1. Materials 108 
 109 
Griseofulvin 97%, silicon dioxide nanopowder 99.5%, microcrystalline 110 
cellulose (MCC) and polyvinylpyrrolidone (PVP) K30 were purchased from 111 
Sigma-Aldrich (Dorset, UK). Hydroxypropyl methylcellulose acetate succinate 112 
(HPMCAS) was obtained from Shin-Etsu Chemical Co. Ltd (Tokyo, Japan). 113 
Acetone, chloroform and methanol were purchased from Fisher Scientific 114 
(Loughborough, UK). Ethanol, potassium dihydrogen phosphate, KH2PO4 115 
and sodium hydroxide, NaOH pellets were obtained from VWR International 116 
(Leicestershire, UK). 117 
 118 
 119 
2.2. Dynamic vapor sorption 120 
Solid dispersions of GF (10 mg) were weighed at 25 °C using a Dynamic 121 
Vapor Sorption analyzer (SMS, UK). Two sources of nitrogen gas were used 122 
where one of them is a dry gas while the second is 100% moist.  By mixing 123 
both of them, the desirable relative humidity was obtained.  The variation in 124 
weight was recorded using a two-arm balance where the reference pan was 125 
empty and the sample pan was filled with the sample.  Nitrogen gas was 126 
passed over the sample to remove the residual solvent content (using 0% 127 
relative humidity).  Once this was achieved, nitrogen gas is passed with the 128 
desired relative humidity (RH).  129 
 130 
2.3. Differential Scanning Calorimetry (DSC)  131 
Thermal analysis was performed on a 2920 TA Instruments (Hertfordshire, 132 
UK) differential scanning calorimeter calibrated with indium using a purge of 133 
nitrogen gas at 20mL/min. A pinhole was created on an aluminium lid (TA 134 
instruments) to remove residual solvent. 8-10mg of sample was loaded into 135 
an aluminium pan and hermetically sealed. The samples were scanned from 136 
10ºC to 250ºC using a heating rate of 10ºC/min.  The melting enthalpy, onset 137 
and peak melting temperature were recorded and their values represent an 138 
average value of triplicates.  139 
 140 
 141 
2.4. Fourier transform infrared spectroscopy (FTIR) 142 
FTIR was performed on the prepared dispersions to examine potential 143 
hydrogen bonding between GF and the polymers. The infrared spectra of 144 
samples were obtained using Perkin Elmer Spectrum One FTIR spectrometer, 145 
equipped with a diamond attenuated total reflectance (ATR) accessory 146 
(Shelton, Connecticut, USA). A total of 64 scans were collected for each 147 
sample with a resolution of 4cm-1 from a frequency range of 4000cm-1 to 148 
550cm-1.  149 
 150 
2.5. Saturation solubility measurements  151 
From each solid mixture quantities equivalent to 5mg-10mg equivalent of 152 
griseofulvin was weighed. 1mL of phosphate buffer was added into the 153 
microtube which was then loaded on a Stuart SB2 rotary mixer (Staffordshire, 154 
UK) and mixed for 1, 3, 5 and 72 h.  This was followed by centrifugation for 10 155 
min at 13000 RPM on a Heraeus Biofuge Pico 24-place microliter centrifuge 156 
(Thermo Scientific, Hertfordshire, UK). The supernatant was separated and 157 
the UV absorbances of the supernatants were measured using a Thermo 158 
Scientific Spectronic spectrophotometer (Thermo Scientific, Waltham, USA) 159 
using a wavelength of 295nm.  Absorbance values were converted into 160 
solubility values using standard calibration curve of griseofulvin.  Solubility 161 
studies were conducted in triplicates and the average and standard deviations 162 
were calculated.  163 
 164 
 165 
2.6. Temperature controlled X-ray powder diffraction  166 
The polymorphic nature of the formed samples was studies using x-ray 167 
powder diffraction (XRPD).  All samples were scanned using a Bruker D8 168 
advance X-ray diffractometer (Bruker AXS GmbH, Germany) which is a Cu-169 
source, theta– theta diffractometer equipped with a Lynx eye position 170 
sensitive detector. It was operated at 40 kV generator voltage and 40 mA 171 
generator current. The samples were analysed using DFFRAC plus XRD 172 
commander software (Bruker AXS GmbH, Germany) with a 2θ range of 5-45°, 173 
a step size of 0.02°and time per step of 1.33s.   Glass Capillary x-ray 174 
diffraction data were collected on Bruker D8 Advance Material lightly ground 175 
and packed in 0.7 mm capillary, which was then heated with a co-axially, 176 
mounted cryostream.  Compact controller set to ramp to temperature, then 177 
held for 5 minutes to allow the capillary to warm up, before collecting data. 178 
This was followed by a ramp to next temperature, hold, collect cycle within a 179 
temperature range of 30-200 °C. 180 
 181 
2.7. Solid and liquid state NMR  182 
Solid and liquid state NMR studies were used to investigate structural 183 
changes of GF within the solvated and non-solvated polymeric matrices.  1H 184 
and 13C NMR spectra of GF chloroform-d solution were recorded on Bruker 185 
Avance III spectrometer (Bruker, Germany) operating at Larmor frequency of 186 
500 MHz (11.75T) and 125.78 MHz, respectively. The 32 transient were 187 
recorded and average into each 1H spectrum. The proton decoupled 13C 188 
experiment required 1024 transients, and was recorded with 8 sec relaxation 189 
delay. The selected 2D experiments (e.g. COSY, TOCSY, HSQC and HMBC) 190 
were also recorded to confirm the assignments of the GF peaks to the 191 
molecular structure (data not shown). All spectra were referenced using TSP 192 
signal at 0 ppm. 193 
 194 
The 13C solid-state cross-polarization magic angle spinning (CPMAS) NMR 195 
spectra were recorded on Bruker Avance III spectrometer (Bruker, Germany) 196 
operating at Larmor frequency of 125.78 MHz (11.75T). The standard bore 197 
MAS probe was used in conjunction with 4 mm diameter zirconia rotors, which 198 
were spun at 10 kHz rate.  The CP contact time was 2.0 ms, and the 90° 199 
pulse width was 3.7 us at a power level of 32 W. Between 256 (for GF and 200 
HPMCAS) and 1024 (all other samples) signal transients were accumulated 201 
with 6 sec relaxation delays at ambient temperature.  All spectra were 202 
referenced to external adamantane signal as a secondary reference 203 
(frequency peak at 38.0 ppm). 204 
 205 
2.8. Preparation of drug-polymer solvates and non-solvated 206 
counterparts   207 
Fixed weight ratios (w/w ratios) of GF and polymer, i.e. silica, microcrystalline 208 
cellulose (MCC), polyvinylpyrrolidone  (PVP) and hydroxypropyl 209 
methylcellulose acetate succinate (HPMCAS) were weighed and fully 210 
dissolved in solvent of choice (acetone, methanol or chloroform) which was 211 
then removed using rotary evaporator (Buchi Rotavapor RE-111, Oldham, 212 
UK) with a set water bath temperature of 40 °C.  The solid remained in the 213 
flask was transferred to another container and placed under vacuum to be 214 
dried for 24h to eliminate any residual solvent. The resultant solid was co-215 
ground for 10min and sieved via 80 μm sieve.   216 
 217 
2.9. Preparation of fungal inoculum 218 
In order to study differences among prepared formulations, in vitro studies 219 
were carried out using fungal biofilms. T. rubrum NCPF 935 (PHE, UK) 220 
inoculum was prepared from initial growth on potato dextrose agar (PDA) 221 
(Sigma-Aldrich, UK) as mentioned by Brilhante et al., 2017 with a few 222 
modifications [15]. Briefly, 39 g/L of the solids were fully dissolved in 1 L of 223 
distilled water and then sterilised at 121 oC for 15 min. The molten agar was 224 
poured into petri plates once it had cooled down to ~ 55 oC and allowed to 225 
set. A small piece of T. rubrum NCFP 935 was excised from the stock and 226 
placed in the centre of the PDA plates and allowed to grow for a period of 7-227 
10 days at 28 oC for optimal sporulation. The conidia and hyphal fragments 228 
were harvested by covering the cultures with 5 mL of sterile 0.9% saline 229 
solution and by passing a sterile swab over the surface of the cultures. The 230 
0.9% saline solution containing the conidia and hyphal fragments was then 231 
collected and allowed to settle for 5 min at 28 oC to sediment the hyphae and 232 
separate the conidia. The conidium suspension was then gently aspirated and 233 
transferred to fresh sterile tubes and serially diluted to obtain a suspension 234 
containing ~ 5 x 106 cfu/ mL. This was based on cell count performed using a 235 
haemocytometer. The conidia suspension was then diluted with 0.9% saline 236 
solution to obtain a concentration of ~ 1 x106 cfu/ mL for biofilm formation and 237 
subsequent experiments.  238 
 239 
2.10 Working stock of griseofulvin formulations for biofilm assay 240 
 241 
GF:HPMCAS formulations were initially dissolved in DMSO (dimethyl 242 
sulfoxide) (Sigma-Aldrich, UK) according to the CLSI broth microdilution 243 
protocol (Wayne, 2008) to a concentration of 800 µg/ mL. The formulations 244 
were then further diluted in RPMI 1640 medium, buffered to pH 7 with MOPS 245 
to obtain the desired concentrations for biofilm formation assay.  246 
 247 
2.11. T. rubrum NCPF 935 biofilm formation assay 248 
Biofilm formation by T. rubrum NCPF 935 was performed based on the 249 
method as mentioned by dos Santos and Dias-Souza, 2017; Costa-Orlandi et 250 
al., 2014 with a few modifications [16]. Briefly, 250 µL of the pre-adjusted (~1 251 
x 106 cfu/ mL) conidia suspension was added to 96-well plates as required. 252 
The plates were then incubated at 37 oC for 3 h for adhesion of the conidia to 253 
the surface of the wells under static conditions. Subsequently, the growth 254 
suspension was replaced with pre-sterilised 250 µL of RPMI 1640 (pH 7) 255 
medium containing GF:HPMCAS (chloroform solvate) and non solvated 256 
(prepared from acetone). The concentration of the formulations used in this 257 
study were equivalent to the MIC of griseofulvin against T. rubrum (8 µg/ mL), 258 
which were prepared following CLSI (the clinical and laboratory standards 259 
institute guidelines) M38-A2 for fungal work. Biofilm of T. rubrum NCPF 935 260 
was grown with and without the addition of the formulation and grown for a 261 
period of 96 h at 37 oC prior to carrying out subsequent assays.  262 
 263 
 264 
2.12. Quantification of T. rubrum NCPF biofilm by safranin staining 265 
Biofilm formation by T. rubrum NCPF 935 was performed based on previous 266 
method with a few modifications [16, 17]. Briefly, 250 µL of the pre-adjusted 267 
(~1 x 106 cfu/ mL) conidia suspension was added to 96-well plates as 268 
required. The plates were then incubated at 37 oC for 3 h for adhesion of the 269 
conidia to the surface of the wells under static conditions. Subsequently, the 270 
growth suspension was replaced with pre-sterilised 250 µL of RPMI 1640 (pH 271 
7) medium containing GF:HPMCAS (chloroform solvate) and non solvated 272 
(prepared from acetone). The concentration of the formulations used in this 273 
study were equivalent to the known MIC90 of griseofulvin against T. rubrum (8 274 
µg/ mL) as demonstrated previously [18] were prepared following clinical and 275 
laboratory standards institute (CLSI) guidelines M38-A2 for fungal work. 276 
Biofilm of T. rubrum NCPF 935 was grown with and without the addition of the 277 
formulation and grown for a period of 96 h at 37 oC prior to carrying out 278 
subsequent assays.  279 
The concentration of GF:HPMCAS (solvated and non-solvated) used in this 280 
study are provided in Table 1 (supplementary material). The total 281 
concentration (w/v) of GF:HPMCAS used for the in vitro studies was based on 282 
MIC90 of GF as per published literature. DMSO when diluted in RPMI without 283 
the formulations did not exhibit any inhibitory effects on T. rubrum NCPF 953. 284 
 285 
2.13. Metabolic activity of T. rubrum NCPF 935 by XTT assay 286 
XTT assay was used based on the method described by Costa-Orlandi et al., 287 
2014 with a few modifications [16]. The assay was used in this study to 288 
quantify the metabolic activity of the biofilm with and without the presence of 289 
the formulations. Stock solutions of XTT (2,3-bis (2-methoxy-4-nitro-5-290 
sulfophenyl)-5- [carbonyl (phenylamino)]-2H-tetrazolium hydroxide) and 291 
menadione were prepared, 1 mg/mL in PBS and 1 mM ethanol respectively, 292 
and stored at 4 oC. T. rubrum NCPF 935 biofilms were grown with and without 293 
the presence of the formulations that showed the highest biofilm inhibition. 294 
Samples were analysed at 3, 8, 24, 48, 72 and 96 h. To the samples, 50 µL of 295 
XTT solution was added along with 4 µL of menadione into the 96-well plates 296 
and incubated at 37 oC for 3 h. The resulting formation of formazan salts and 297 
colorimetric change were measured in a plate reader at 490 nm (FLUOstar 298 
Optima, BMG labtech, UK). RPMI 1640 medium, free of biofilm was used as a 299 
negative control.  300 
 301 
2.14. Protease activity of T. rubrum NCPF 935 302 
Proteolytic activity of T. rubrum NCPF 935 was measured with and without the 303 
presence of formulations. The method used in this study was based on Al-304 
Janabi and Al-Hamadani, 2015 with a few modifications [19]. Briefly, T. 305 
rubrum NCPF 935 was grown in PDB (potato dextrose broth) (Sigma-Aldrich, 306 
UK) at 37 oC in a rotary shaker at 4 RCF for 7 days. Casein from bovine milk 307 
(1% w/v) (Sigma-Aldrich, UK) was used to determine the proteolytic activity. 308 
Briefly, to 500 µL of the casein substrate, 500 µL of T. rubrum NCPF 935 309 
filtrate treated with and without the formulations was added along with 100 µL 310 
of 0.5 M tris-HCL (pH 8) in test tubes. The reaction was carried out at 40 oC 311 
for 30 min and stopped by adding 2 mL of 0.67 M trichloro acetic acid (TCA). 312 
The test tubes were allowed to rest at room temperature for 1 h. The 313 
precipitate formed was removed by centrifugation at 5000 rpm for 15 min. The 314 
absorbance was then measured at 280 nm using a spectrophotometer against 315 
a blank where TCA was added prior to the incubation period. Unit of 316 
enzymatic activity was defined as the amount of enzyme that produced 317 
products by breaking down casein giving an absorbance of 0.1 at 280 nm 318 
under the experimental conditions. The following formula was used to 319 
calculate the activity of protease per mg of protein.  320 




2.15. Confocal laser scanning microscopy of T. rubrum NCPF 935 325 
biofilm 326 
Biofilms of T. rubrum NCPF 935 were grown in 6-well tissue culture (Nunc) 327 
plates in RPMI-1640 medium at 37 oC for a period of 72 h with and without the 328 
addition of GF:HPMCAS (chloroform solvate) and non solvated (prepared 329 
from acetone). FUN-1 (Molecular probes, Invitrogen) was prepared according 330 
to manufactures instructions and was used to stain T. rubrum NCPF 935 331 
biofilm as mentioned by Costa-Orlandi et al., 2014 with a few modifications 332 
[16]. Briefly, the biofilm was gently washed using 0.9% (v/v) saline solution 333 
and treated with 300µL of FUN-1 fluorescent stain for 45 min and incubated at 334 
37oC protected from light. After the incubation period, the excess stain was 335 
gently washed using HEPES buffer after which, the biofilms were visualised at 336 
~485 nm excitation/ ~530 nm emission (green) using a Leica TSC SP2 337 
confocal microscope (Heidelberg, Germany).  338 
 339 
2.16. Data analysis 340 
All experiments were conducted in triplicate unless mentioned otherwise. 341 
Statistical analysis was conducted using one-way ANOVA (Tukey's multiple 342 
comparision test). A P value of < 0.05 was considered to be significant. Data 343 
processing was performed using GraphPad Prism 7 for windows, GraphPad 344 





3. Results  350 
3.1. Thermal analysis of GF solid dispersions 351 
Assessment of drug/polymer interaction was based on solid solubility, which 352 
was evaluated using melting point depression of corresponding physical 353 
mixtures (Fig 1).  As can be seen in Fig. 1, GF-HPMCAS showed lowest 354 
depression of approximately 50 °C.  On the contrary there was minimal 355 
change in GF melting in silica and MCC dispersions signifying minimum 356 
impact on the crystallinity of GF.  Due to degradation of PVP, measurement of 357 
GF melting in GF/PVP was not possible.  358 
 359 
The solvated solid dispersions were also evaluated to determine any changes 360 
in the melting point (Fig 1). Formation of the GF solvate was evident in the 361 
DSC thermograms where an endothermic peak was clearly visible at 362 
approximately 97°C (Fig. 1). This peak corresponds to the melting of 363 
chloroform solvate crystals, which was confirmed via cooling cycle that 364 
showed disappearance of this endotherm.   The endotherm seen was 365 
significant with a heat of fusion of approximately 84 J/g.  Once the solvate 366 
melted, another endothermic event was seen at higher temperature attributed 367 
to the melt of the GF free crystals (non-solvated).  The melting endotherm 368 
onset of GF was 218 °C for GF prepared in chloroform (solvated), 220 and 369 
219 °C for GF prepared in acetone and methanol (non-solvated), respectively.   370 
The heat of fusion of crystalline GF was 86 J/g and reflected the presence of 371 
the chloroform solvate because the heat of fusion for GF re-crystalized in 372 
acetone and methanol was 115 J/g.   This difference in heat of fusion reflects 373 
a mixture of crystalline structures, i.e. crystalline GF and crystalline GF-374 
chloroform crystals.  These results agreed with previous research on GF 375 
solvates where the melting of the solid-chloroform solvate occurred at 147 °C 376 
[20].  The lower melting peak in our results is caused by the mixing with 377 
different polymers which affected the onset of the endotherm but not the 378 
extent of solvation. As can be seen in Fig. 1, the chloroform solvate peaks 379 
were observed in the temperature range 85-135 °C.  Differences in the 380 
melting onset seen among different excipients reflect variations in molecular 381 
interactions where HPMCAS dispersions showed lowest onset of solvate 382 
melting. Variation of the molar ratio of the solvent-GF were found previously to 383 
affect the onset of the melt as was shown for different solvates [21]. This 384 
possible variation was avoided via using similar ratio of the solvent throughout 385 
this study.   386 
 387 
 388 
3.2. Characterization of formed dispersions by XRPD  389 
The effect of the polymer on solvate formation was studied by analysing the 390 
crystalline patterns (Fig. 2). The evidence of the solvate form was confirmed 391 
by the observation of the peaks at 11.3°, 15.3° and 26.5°.  .  It was also clear 392 
that some of the peaks were less intense in the drug/polymer mixtures. This 393 
could indicate presence of the partially amorphous form formation because of 394 
the influence of the polymer. 395 
 396 
The formation of the solvate was investigated further and the results can be 397 
seen in Fig. 2. New peaks were seen in the scan at 2θ of 11.2°, 15.3°, 17.5°, 398 
22.5°, 26.5° while other peaks such as at 10.8°, 28° and 32.8° diminished in 399 
the chloroform GF solvate.  These results indicate that the GF chloroform 400 
solvate was formed.  It was still possible to observe other peaks, which 401 
indicates that the formed solvate contributed only partially to the crystalline 402 
structure of GF.   Changes from the chloroform solvate orthorhombic form to 403 
non-solvated tetragonal (depicted from the crystalline structures) were 404 
observed when temperature was increased from 30 to 200 °C and the solvate 405 
disappeared completely at 120 °C.   These results were similar for all drug-406 
polymer combinations.  The peaks positions, and in particular at 11.2°, were 407 
changing gradually and started to appear at 80 °C.  408 
 409 
 410 
Fig. 2: (A) X-ray powder diffraction scans of 1:1 (GF : polymer) prepared in 411 
acetone, chloroform and methanol and (B) X-ray powder diffraction scans of 412 
1:1 (GF:HPMCAS) chloroform solvate as a function of temperature showing 413 
polymorphic changes that start to occur ~90 °C.  These changes result from 414 
the loss of the solvate structure at this temperature range.  415 
 416 
3.3. Hydrogen bonding analysis of polymer-GF interactions  417 
While the formation of GF solvates was reported previously for different 418 
solvents [22, 23], limited studies were carried out of solvated polymeric 419 
dispersions. Fig. 3 shows the FTIR spectra obtained from 1:1 GF-polymer 420 
solid dispersions in acetone, chloroform and methanol.  The very broad peak 421 
at 1730-1750cm-1 is associated with the carbonyl group stretching of 422 
HPMCAS. The peaks at 1705cm-1 and 1657cm-1 correspond to the stretching 423 
of the benzofuran and cyclohexene carbonyl groups in GF [24].  In the 424 
chloroform solid dispersion these peaks have shifted to 1694cm-1 and 1666 425 
cm-1 respectively, indicating the presence of hydrogen bonding between 426 
griseofulvin and chloroform.  427 
 428 
The peaks at 1615cm-1 and 1585cm-1 are typically associated with the C=C 429 
stretch of the aromatic ring in griseofulvin. Interestingly, in the spectrum of the 430 
chloroform solid dispersion the small peak at 1599cm-1 which represents the 431 
aromatic C=C stretch in griseofulvin disappears. Its absence indicated 432 
significant polymorphic changes.  The shifts were identical among different 433 
polymers, which indicated predominant impact of the solvent (chloroform) in 434 






3.4. Effect of different polymers on the solubility of griseofulvin (GF)  441 
The saturation solubility of GF solid dispersions prepared in acetone, 442 
chloroform and methanol are shown in Fig. 4. The solubility of GF chloroform 443 
solvate was the lowest compared to that prepared from acetone or methanol 444 
(35, 45 and 70 μg/mL, respectively).  However, as shown in Fig. 4, 445 
incorporation of the polymers has increased the solubility of the chloroform 446 
dispersion compared to GF alone.  The extent of this enhancement ranged 447 
from 31% for GF-MCC to 132.9% for GF-HPMCAS solid dispersions as 448 
measured after 72 hours.  The solubility patterns in the initial 5 hours were 449 
largely similar to that of saturation solubility, with HPMCAS being the most 450 
soluble and MCC being the lowest in this ascending order: MCC < silica < 451 
PVP < HPMCAS.  452 
 453 
The ability of HPMCAS to improve drug dissolution and prevent drug 454 
recrystallization was also evident.  HPMCAS proved to be the most effective 455 
polymer to enhance solubility, with an increase up to 150%.  This was 456 
particularly evident in GF-HPMCAS chloroform solvate, which outperformed 457 
the GF-HPMCAS in acetone solid dispersion by as much as 73%. 458 
Improvements in solubility were also evident in all other polymers, with the 459 
exception of silica, which solubility is almost similar to that in acetone 460 








3.5. Antifungal activity of solvate dispersions  469 
Formation of a biofilm is essential in the pathogenicity of T. rubrum to cause 470 
chronic superficial fungal infections such as onychomycosis (fungal nail 471 
infections). In vitro growth of T. rubrum NCPF 935 and subsequent antifungal 472 
assays displayed a significant reduction in the biofilm production (p < 0.0001) 473 
after the exposure to GF:HPMCAS chloroform solvate and non-solvated 474 
GF:HPMCAS prepared from acetone when compared to the untreated 475 
control.. GF chloroform solvate was found to be more effective in antagonising 476 
the production of the biofilm compared to non-solvated GF prepared from 477 
acetone as shown in Fig. 5 (a, b, c). As both forms of GF showed significant 478 
reduction in biofilm compared to the untreated control, this in turn reflects the 479 
impact of preparing the drug as a solid dispersion and the possible 480 
antagonistic activity of HPMCAS towards the negating the pathogenicity of T. 481 
rubrum. The antifungal activity of solvated (chloroform) and non- solvated 482 
(acetone) GF against T. rubrum NCPF 935 is clearly observed with the XTT 483 
assay wherein a significant reduction in metabolic activity was observed after 484 
8h (Fig 5). This decreased metabolic activity was observed for the entire 485 
duration of the experiment starting 8h at time point. Data obtained from the 486 
XTT assay correspond to the reduction of the biofilm with the treatment due to 487 
lowered activity of T. rubrum NCPF 935 and its ability to produce biofilm.   As 488 
shown in Fig 5, the GF chloroform solvate and non-solvated GF prepared 489 
from acetone showed a significant reduction in protease activity. This reflects 490 
reduced keratinolytic activity, which is important to note as one of the primary 491 
virulence factors of dermatophytes.   492 
 493 
 494 
Formation of hyphae is a prerequisite for fungal attachment to a substratum 495 
and formation of the biofilm. Assessing the effect of GF formulations on T. 496 
rubrum NCPF 935 hyphae and biofilm development by Confocal laser 497 
scanning microscopy showed a change in morphology of T. rubrum NCPF 498 
935 hyphae (density, thickness) as well as absence of conidia with treatment 499 
after a period of 72 h. Treatments therefore showed significant antagonism 500 
towards hyphal formation and subsequent propagation and spread of the 501 
fungi. Similarly, absent conidia signify the reduced ability of T. rubrum NCPF 502 
935 to sporulate, thereby negating the spread of the infection.  503 
 504 
The chloroform solvate of GF-HPMCAS was found to have a higher impact on 505 
inhibiting the biofilm development of T. rubrum NCPF 935. This could be 506 
clearly seen in Fig 5, as thicker hyphae but not as dense were observed in 507 
GF-HPMCAS dispersions (non-solvated).  On the contrary, significant 508 
reduction in the thickness and density as thin hyphae could be seen in the 509 
GF-HPMCAS dispersions (solvated). Overall, a lack of conidia in T. rubrum 510 










3.6. Analysis of solid and liquid state interactions using solid and liquid 521 
state NMR 522 
Solvated GF-HPMCAS dispersion showed higher antifungal activity when 523 
compared to non-solvated form.  To fully understand the mechanism of this 524 
enhancement, it is important to find whether the crucial interactions, which 525 
were established in the liquid state, are also retained in the solid state. 526 
Nuclear magnetic resonance (NMR) is particularly suited to tackle such a 527 
problem because its offer direct inside into molecular structure in the solution 528 
(liquid state NMR) and solid (solid-state NMR) and its able to provide detailed 529 
information on a very subtle interactions, including hydrogen bonds. 530 
 531 
To be able to correctly compare and analyse solution and solid-state NMR 532 
results, the full assignment of all signals in 13C NMR spectra of GF was 533 
required (Fig. 6 and Table 1). The assignment of the signals in13C NMR 534 
spectrum of GF was found to be in good agreement with previously published 535 
data [25] as presented in Fig. 6A and Table 1. 13C solid-state NMR spectrum 536 
of pure GF showed the presence of additional signals (195 ppm and new 537 
signal between 91 and 90 ppm), which could not be attributed to spinning 538 
sidebands. This strongly suggests the coexistence of different isomers, 539 
possibly with distinctive patterns of hydrogen bonding in the crystalline 540 
dispersion as observed before [26].  This is supported by the observation that 541 
resonances from the carbons C5, C2 which should be particularly sensitive to 542 
hydrogen bonding are present around 195 ppm and in the region between 95 543 
and 90 ppm.  544 
 545 
The 13C solid-state NMR spectra of GF, HPMCAS and GF and HPMCAS 546 
dispersions are compared in Fig. 6B. There was no significant difference 547 
between the spectra of physical mixture of GF and HPMCAS and a sum of the 548 
separate GF and HPMCAS spectra (Fig. 6B).  This suggests negligible 549 
interaction in the physical mixture regardless of any conformational 550 




  555 
Fig. 6B (ii-v) compares 13C solid-state NMR spectra of GF:HPMCAS 556 
dispersions prepared from chloroform, acetone and methanol with the 557 
spectrum of the physical mixture. For dispersions prepared from methanol, no 558 
differences were observed in the chemical shifts between the physical mixture 559 
and methanol dispersion indicating minimum impact of methanol on the 560 
formation of the dispersion.  On the other hand, the dispersion prepared using 561 
acetone showed significant broadening of the signals attributed to GF with 562 
mostly unchanged HPMCAS signals. For example, peaks at 97.9 and 94.5 563 
ppm have merged into one broad structure at 96 ppm. These changes 564 
indicate the formation of amorphous GF dispersion, which agreed with the 565 
XRPD data shown above.   566 
 567 
When comparing the chemical shifts in the spectra of the dispersion prepared 568 
from chloroform, significant changes were observed especially for C14 and 569 
C21 carbons (Table 1, Fig. 6A). The downfield shift in δC14 (δsolid < δsolution < 570 
δcomplex) suggests that stronger hydrogen bonding in the chloroform complex 571 
compared to chloroform solution.  In general, there were significant 572 
differences in the carbon chemical shift between solution, complex – 573 
dispersion and crystalline samples. This is consistent with the highly 574 
constrained crystalline structure, compared with the solution where mobility of 575 
the methyl groups is less restricted. Furthermore, general analysis of the 576 
chemical shifts, suggests that the structure of the chloroform complex-577 




4. Discussion  582 
GF was shown before to have weak activity against T. rubrum isolates [27]. 583 
However, in our work, the metabolic and protease activity of T. rubrum NCPF 584 
935 with and without the presence of GF:HPMCAS chloroform solvates 585 
showed significant reduction compared to the untreated control after 24 h 586 
period.   This was clearly visible in confocal laser scanning microscopy which 587 
showed disappearance of the hyphae compared to Control and GF:HPMCAS 588 
(non solvated).  Chloroform extracts were shown before to have low activity 589 
against T. rubrum fungal strains [28].  Therefore, results shown demonstrate 590 
novel role for the polymeric dispersion in augmenting the activity of the 591 
antifungal drug GF.    592 
 593 
HPMCAS solvate dispersions were more stable when compared with other 594 
polymers, which may explain the observed synergistic effect.  As can be seen 595 
in Figure 7, dynamic vapour sorption data showed recrystallization of all 596 
solvate dispersions when the relative humidity was increased to around 70%.  597 
The loss in mass was a sign of loss of bound and non-bound water (or 598 
solvate). No recrystallization (or solvate loss) could be observed in HPMCAS 599 
solvate dispersions upon sorption and desorption cycles which indicates that 600 
the solvates maintained their structures when exposed to water.   601 
 602 
 603 
Hydrogen bonding between the hydrogen in chloroform molecule and the 604 
carbonyl on GF explains the basis for GF chloroform solvate formation, which 605 
was clearly visible in the FTIR analysis.   This ability to form hydrogen 606 
bonding is based on the fact that chloroform acts as Lewis acid with the 607 
potential to form hydrogen bonds with corresponding bases [29, 30].  When 608 
different polymers were incorporated, the GF solvate was affected.  For 609 
example, HPMCAS resulted in the disruption of the solvate crystalline lattice 610 
likely by formed hydrogen bonding as was shown in 13C solid-state NMR 611 
spectra. Polymorphic changes were confirmed using XRPD where data 612 
showed despite that part of GF existed as amorphous; the main polymorphic 613 
structure was the solvate form.  This was clear in Fig 2 where the increase in 614 
the temperature to 80°C was associated with the disappearance of the 615 
solvate and appearance of form I GF polymorph.  The extensive hydrogen 616 
bonding for GF-HPMCAS chloroform solvate has been shown to enhance the 617 
solubility of GF.  This trend has also been seen for PVP where improvement 618 
in solubility could also be observed when compared with the solubility of silica 619 
and MCC dispersions.  620 
 621 
 622 
This suggests that solvates, which were formed in the liquid state, maintained 623 
their structures in the solid state.  Such behaviour was reported previously 624 
where lithium solvates were shown to remain stable in solutions of aprotic 625 
solvents and affected the properties of those solutions [31].  Similarly, it is 626 
possible that solvates formed from chloroform maintained their molecular 627 
structure and assisted in enhancing solubility via Cl…Cl interactions together 628 
with the formed hydrogen bonds with GF and HPMCAS.   This could be 629 
possible reason for the increased antifungal activity of GF-HPMCAS solvate, 630 
which was 2-5 times stronger when compared with the activity of GF alone.  631 
Synergistic effect was also caused by prevention of recrystallization and 632 
solvate expulsion as evident in Fig. 7, which could explain the disruptive effect 633 




5. Conclusions  638 
The results of this work showed that the griseofulvin solvate had a 639 
significantly higher antifungal activity against dermatophytes compared to 640 
non-solvated form.  This synergistic effect was achieved by carefully planned 641 
crystal engineering in which the drug properties were changed via dispersing 642 
it into a matrix.  Solvated crystals of griseofulvin embedded within the 643 
HPMCAS matrix showed higher dissolution properties with evidence of 644 
hydrogen bonding.  The most significant impact of these distinctive molecular 645 
interactions present in the solvate form was observed in the antimicrobial 646 
assay where the fungal threads dramatically diminished when treated with the 647 
chloroform solvate form of griseofulvin.   Solution and solid-state NMR 648 
experiments demonstrated that solvent molecules play important role in the 649 
formation of very specific microstructure of the GF solid dispersions. In 650 
particular, the interaction between GF and chloroform were found to be similar 651 
in solution and solvate, which could be responsible for the unique properties 652 
of the solvate. Our findings further signify the role of precise crystal 653 
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Legend to Tables and Figures 787 
 788 
Supplementary Table 1: Typical in vitro concentrations of GF:HPMCAS used 789 
in relation to MIC90 of GF  790 
 791 
Table 1: A summary of NMR chemical shifts as measured for GF:HPMCAS 792 
(1:1) using 13C CPMAS and 13C liquid NMR and their assignment to the 793 
molecular structure of GF (see Fig. 6A for full numbering of carbon atoms). 794 
 795 
Fig. 1: Thermograms of GF mixtures with polymers (A) showing the melting 796 
point of GF in physical mixtures with the polymers, and (B) showing 797 
thermograms of solid dispersions prepared in chloroform, methanol, acetone 798 
using a weight ratio of 1:1. The chloroform solvate peaks can be seen in the 799 
temperature range 85-135 °C. 800 
 801 
Fig. 2: (A) X-ray powder diffraction scans of 1:1 (GF : polymer) prepared in 802 
acetone, chloroform and methanol and (B) X-ray powder diffraction scans of 803 
1:1 (GF:HPMCAS) chloroform solvate as a function of temperature showing 804 
polymorphic changes that start to occur ~90 °C.  These changes result from 805 
the loss of the solvate structure at this temperature range.  806 
 807 
Fig. 3: FTIR scans of 1:1 (GF : polymer) prepared in acetone, chloroform and 808 
methanol showing significant changes in the chloroform solvates as reflected 809 
in the stretching vibrations highlighted by the shaded bars. 810 
 811 
Fig. 4: saturated solubility measurements showing solubility of pure GF 812 
crystallized from different solvents and GF : polymer (1:1) prepared using 813 
different solvents.  Measurements were performed in a phosphate buffer 814 
(pH=6.8), t=72 hours , n=3.  815 
 816 
Fig. 5: (A) Quantification of biofilm formed by T. rubrum NCPF 935 by 817 
safranin staining. Compared to the control, the use solvated and non solvated 818 
GF:HPMCAS dispersions showed a significant reduction in biofilm content (p< 819 
0.0001), (B) Metabolic activity of T. rubrum NCPF 935 with and without the 820 
presence of formulations GF:HPMCAS (chloroform solvate) and GF:HPMCAS 821 
non solvated (prepared from acetone) showed a significant reduction 822 
compared to the untreated control after 24 h period 96 h (n=3), (C) 823 
Quantification of protease activity by T. rubrum NCPF 935 showing significant 824 
reduction (p< 0.0001) in protease activity (n=5) and (D) confocal laser 825 
scanning microscopy images of T. rubrum NCPF 935 with and without 826 
treatment after 72 h (magnification at 630x). i) Control T. rubrum growth 827 
shows conidia (white arrows) and dense hyphae. ii) Treatment with 828 
GF:HPMCAS non solvated (prepared from acetone) showed thicker hyphae 829 
but not as dense. iii) Treatment with GF:HPMCAS (chloroform solvate) 830 
showed thin hyphae compared to Control and GF:HPMCAS non solvated 831 
(prepared from acetone).  832 
 833 
Fig. 6: (A) Molecular structure of GF and the assignment of the carbon atoms 834 
to the resonances recorded in (ii) solid-state and (i) solution 13C NMR spectra. 835 
(B) Comparison of 13C solid-state NMR spectra of (i) GF and HPMCAS, (ii) 836 
physical mixture of GF and HPMCAS, and GF:HPMCAS dispersions prepared 837 
from (iii) chloroform, (iv) acetone and (v) methanol.  838 
 839 
Fig. 7: Dynamic vapur sorption isotherms for GF solid dispersions prepared 840 
using chloroform.  841 
 842 
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